Safety Study of RMJH-111b to Treat Essential Hypertension
Status:
Completed
Trial end date:
2016-07-07
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the safety of RMJH-111b, including how well it is
tolerated, and the effect of RMJH-111b on blood pressure in subjects with hypertension. The
study also measured the amount of magnesium in the blood and urine before and after RMJH-111b
administration to evaluate what the body does to RMJH-111b (pharmacokinetics).